【制药网 行业动态】昨日(7月31日)，国药集团旗下上市公司上海现代制药股份有限公司(以下简称“国药现代”)发布公告称，公司于2025年7月30日在上海联合产权交易所公开挂牌，以挂牌底价人民币1.55亿元，转让所持有的上海现代哈森(商丘)药业有限公司(以下简称“国药哈森”)51%股权。此次剥离一方面是因为国药哈森目前在销品种规模较小，且与公司下属其他子公司产品重叠度较高；另一方面，2021年以来，...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.